is there a tirzepatide shortage Ends 🛑BREAKING NEWS🛑 THE FDA OFFICIALLY

Treatment involves the use of one of several GLP-1 analogue drugs like Wegovy or Mounjaro

You also are not able to claim that the compounded drugs are FDA approved or have an FDA-approved use, or even that the drugs effectiveness was proved in clinical trials, because those all describe the name-brand drugs

NICE also limits treatment duration to a maximum of 2 years and recommends discontinuation if less than 5% weight loss is achieved after around 6 months at the maintenance dose

At Bee Well, we take great pride in our innovative approach to healthcare

The specific transition protocol accounts for receptor adaptation from prior dual agonist use

Tirzepatide, a dual GIP/GLP-1 agonist, is available under two brand names: Mounjaro and Zepbound